Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system
“The device takes variability out of the procedure by giving the operator full control while automating ramp-up and back-up algorithms," according to a clinician who used the new technology. "The TAVR procedure is simplified, reducing physician and staff workload."

For high-risk AF patients, NOACs outperform warfarin

Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open.

FDA approves emergency use of Abiomed’s Impella RP heart pump for certain COVID-19 patients

The emergency use authorization covers patients who experience right-sided heart failure following left ventricular assist device implantation, myocardial infarction, heart transplant or open-heart surgery.

How health literacy can impact heart failure patients

The study's authors emphasized the importance of interventions such as patient communication and education.

FDA recalls multiple lots of extended-release metformin due to contamination

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

Cancer patients with COVID-19 have higher risk of death

Cancer patients also diagnosed with COVID-19 are much more likely to die compared to the general public, according to a new study published in The Lancet.

4 cardiac arrhythmias associated with COVID-19

The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU.

Healthcare companies are returning COVID-19 relief funds

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

‘Everyone is shocked’: Celebrated cardiologist dies from COVID-19 complications

Eugene “Gene” J. Sayfie, MD, a veteran cardiologist from Miami, died from COVID-19-related complications on May 23. He was 85 years old.

Clinical

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system